ATRX and pancreatic neuroendocrine tumor: In a case report on one patient with metastatic pancreatic NET G−3, the whole-genome sequencing of liver metastases exhibited a TSC1-disrupting fusion, showed a novel CHD7–BEND2 fusion, but lacked any somatic variants in ATRX, DAXX, and MEN1 [20].